142 related articles for article (PubMed ID: 7537438)
1. Streptokinase-prostacyclin--nitric oxide: in vivo interactions.
Gryglewski RJ; Swies J
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():479-84. PubMed ID: 7537438
[No Abstract] [Full Text] [Related]
2. On the mechanism of thrombogenesis during pharmacological thrombolysis.
Korbut R; Gryglewski RJ
Pol J Pharmacol; 1996; 48(1):85-8. PubMed ID: 9112633
[TBL] [Abstract][Full Text] [Related]
3. Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro.
Starzyk D; Korbut R; Gryglewski RJ
J Physiol Pharmacol; 1999 Dec; 50(4):629-37. PubMed ID: 10639013
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA
Cardiovasc Res; 1995 Nov; 30(5):788-98. PubMed ID: 8595628
[TBL] [Abstract][Full Text] [Related]
5. Endothelial secretogogues and deformability of erythrocytes.
Korbut RA; Adamek-Guzik T; Madej J; Korbut R
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):655-65. PubMed ID: 12512700
[TBL] [Abstract][Full Text] [Related]
6. Divergent effects of iloprost and alprostadil on platelets, blood pressure and fibrinolysis.
Witt W; Baldus B
Prog Clin Biol Res; 1989; 301():347-51. PubMed ID: 2477854
[No Abstract] [Full Text] [Related]
7. Effect of prostaglandin I2 analogues on left ventricular diastolic function in vivo.
Kisch-Wedel H; Kemming G; Meisner F; Flondor M; Bruhn S; Koehler C; Messmer K; Zwissler B
Eur J Pharmacol; 2005 Jul; 517(3):208-16. PubMed ID: 15993879
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
9. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
Basista M; Grodzińska L; Swies J
Thromb Haemost; 1985 Dec; 54(4):746-9. PubMed ID: 3911480
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.
Bieroń K; Grodzińska L; Kostka-Trabka E; Gryglewski RJ
Wien Klin Wochenschr; 1993; 105(1):7-11. PubMed ID: 8438599
[TBL] [Abstract][Full Text] [Related]
11. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.
Gryglewski RJ; Grodzińska L; Kostka-Trabka E; Korbut R; Bieroón K; Goszcz A; Sławiński M
Wien Klin Wochenschr; 1996; 108(4):111-6. PubMed ID: 8867484
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide complements prostacyclin in the regulation of endothelial thromboresistance under flow conditions.
Korbut R; Ocetkiewicz A; Gryglewski RJ
Methods Find Exp Clin Pharmacol; 1993 Apr; 15(3):179-81. PubMed ID: 8332034
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin and the vascular endothelium.
Moncada S; Vane JR
Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
[No Abstract] [Full Text] [Related]
14. Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo.
Spiecker M; Darius H; Meyer J
Thromb Res; 1993 Jun; 70(5):405-15. PubMed ID: 7690993
[TBL] [Abstract][Full Text] [Related]
15. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
16. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
[TBL] [Abstract][Full Text] [Related]
17. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
[TBL] [Abstract][Full Text] [Related]
18. Intestinal absorption of calcium in vivo is dependent on endogenous nitric oxide.
Schleiffer R; Galluser M; Raul F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1427-32. PubMed ID: 8531112
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H
Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
[TBL] [Abstract][Full Text] [Related]
20. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
